Amicus Therapeutics, Inc (FOLD) Stock Price

FOLDStock
$0.007.35%52W
Market Cap
P/E
PEG Ratio
Div yield
Beta0.49

FOLD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)65.15%
Price vs S&P 500 (4W)-12.75%
VGM Score43.82

FOLD Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
3.57
3.57
3.57
3.57

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
FOLDAmicus Therapeutics, Inc
DCC$0.00
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Amicus Therapeutics, Inc

Amicus Therapeutics develops precision medicines for rare genetic diseases. Its pipeline includes an oral treatment for Fabry disease, a clinical-stage therapy for Pompe disease, and a rare disease gene therapy platform. The company targets high-impact orphan diseases with limited treatment options.